Injective Labs
Overview
Injective Labs is a research and development company focused on creating unmatched Web3 infrastructure and finance solutions. It is one of the core contributors to Injective. Injective Labs operates through several subsidiaries, including Injective Protocol, Helix, and Mito. Injective Protocol is the first sector-specific blockchain built specifically for finance, offering smart contracts and high interoperability with prominent Layer 1 blockchains. Helix is a decentralized orderbook crypto exchange for trading crypto assets and derivatives, providing zero gas fees and an intuitive user interface. Mito is a next-generation DeFi protocol combining strategy vaults for passive yield generation and a one-click token launchpad. The team at Injective Labs comprises distinguished engineers, traders, and operators with extensive experience across leading industries. The leadership team includes CEO Eric Chen, CTO Albert Chon, Head of Business Development Mirza Uddin, and Head of Engineering David Josse. The company is headquartered in New York, NY, and operates globally, with a team spanning multiple countries and languages. Injective Labs is committed to creating a more free and inclusive financial paradigm through decentralization, with a focus on transparency, collaboration, and pioneering efforts in the Web3 space.
Investment Focus
- Focus on decentralized finance and blockchain technology projects
- Active involvement in the Web3 ecosystem
- Commitment to creating a more free and inclusive financial paradigm through decentralization
Portfolio Companies
Reach Injective Labs directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Injective Labs
What sectors does Injective Labs invest in?
Injective Labs invests in Financial Services, Technology, Asset Management, Software, Investment Management and FinTech, and is based in New York, United States. Injective Labs is listed as a corporate vc in the ConnectSafely investor database.
What stage does Injective Labs invest at?
Injective Labs backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 500K - 5M.
Which regions does Injective Labs invest in?
Injective Labs invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Injective Labs?
Team members listed for Injective Labs include Joan Arcayne (Head of Product) and Julie Lee (Director of Marketing).
What companies has Injective Labs invested in?
Injective Labs's portfolio includes Injective Protocol, Helix and Mito.
How do I contact Injective Labs?
Injective Labs's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
